BAX
Price
$30.39
Change
-$0.11 (-0.36%)
Updated
Jun 27 closing price
Capitalization
21.77B
25 days until earnings call
NHNKY
Price
$11.94
Change
+$0.15 (+1.27%)
Updated
Jun 27 closing price
Capitalization
2.23B
Interact to see
Advertisement

BAX vs NHNKY

Header iconBAX vs NHNKY Comparison
Open Charts BAX vs NHNKYBanner chart's image
Baxter International
Price$30.39
Change-$0.11 (-0.36%)
Volume$3.86M
Capitalization21.77B
Nihon Kohden
Price$11.94
Change+$0.15 (+1.27%)
Volume$3.42K
Capitalization2.23B
BAX vs NHNKY Comparison Chart in %
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. NHNKY commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Buy and NHNKY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BAX: $30.39 vs. NHNKY: $11.94)
Brand notoriety: BAX and NHNKY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BAX: 109% vs. NHNKY: 61%
Market capitalization -- BAX: $21.77B vs. NHNKY: $2.23B
BAX [@Medical Specialties] is valued at $21.77B. NHNKY’s [@Medical Specialties] market capitalization is $2.23B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileNHNKY’s FA Score has 2 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • NHNKY’s FA Score: 2 green, 3 red.
According to our system of comparison, both BAX and NHNKY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 3 TA indicator(s) are bullish while NHNKY’s TA Score has 4 bullish TA indicator(s).

  • BAX’s TA Score: 3 bullish, 6 bearish.
  • NHNKY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NHNKY is a better buy in the short-term than BAX.

Price Growth

BAX (@Medical Specialties) experienced а +1.33% price change this week, while NHNKY (@Medical Specialties) price change was -9.89% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +1.35%, and the average quarterly price growth was -0.23%.

Reported Earning Dates

BAX is expected to report earnings on Jul 24, 2025.

NHNKY is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (+1.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAX($21.8B) has a higher market cap than NHNKY($2.23B). BAX has higher P/E ratio than NHNKY: BAX (85.61) vs NHNKY (18.12). BAX YTD gains are higher at: 5.308 vs. NHNKY (-16.798). NHNKY has higher annual earnings (EBITDA): 27.2B vs. BAX (1.67B). NHNKY has more cash in the bank: 43.7B vs. BAX (3.19B). NHNKY has less debt than BAX: NHNKY (433M) vs BAX (14.4B). NHNKY has higher revenues than BAX: NHNKY (202B) vs BAX (14.8B).
BAXNHNKYBAX / NHNKY
Capitalization21.8B2.23B976%
EBITDA1.67B27.2B6%
Gain YTD5.308-16.798-32%
P/E Ratio85.6118.12473%
Revenue14.8B202B7%
Total Cash3.19B43.7B7%
Total Debt14.4B433M3,326%
FUNDAMENTALS RATINGS
BAX vs NHNKY: Fundamental Ratings
BAX
NHNKY
OUTLOOK RATING
1..100
1550
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9217
PRICE GROWTH RATING
1..100
6080
P/E GROWTH RATING
1..100
1365
SEASONALITY SCORE
1..100
5041

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (9) in the Medical Specialties industry is in the same range as NHNKY (16) in the null industry. This means that BAX’s stock grew similarly to NHNKY’s over the last 12 months.

BAX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NHNKY (100) in the null industry. This means that BAX’s stock grew similarly to NHNKY’s over the last 12 months.

NHNKY's SMR Rating (17) in the null industry is significantly better than the same rating for BAX (92) in the Medical Specialties industry. This means that NHNKY’s stock grew significantly faster than BAX’s over the last 12 months.

BAX's Price Growth Rating (60) in the Medical Specialties industry is in the same range as NHNKY (80) in the null industry. This means that BAX’s stock grew similarly to NHNKY’s over the last 12 months.

BAX's P/E Growth Rating (13) in the Medical Specialties industry is somewhat better than the same rating for NHNKY (65) in the null industry. This means that BAX’s stock grew somewhat faster than NHNKY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXNHNKY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
67%
Momentum
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
73%
MACD
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
54%
Bearish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
63%
Advances
ODDS (%)
Bullish Trend 5 days ago
52%
Bullish Trend 17 days ago
58%
Declines
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 13 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
59%
Bullish Trend 3 days ago
61%
Aroon
ODDS (%)
Bearish Trend 3 days ago
56%
Bullish Trend 3 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAOSX38.530.48
+1.26%
Fidelity Advisor Overseas Z
GGCAX122.401.04
+0.86%
Gabelli Growth A
IGSIX12.370.09
+0.73%
Impax Global Social Leaders Inst
CGREX9.070.02
+0.22%
Invesco Global Real Estate C
ANOCX16.15N/A
N/A
American Century Small Cap Growth C

NHNKY and

Correlation & Price change

A.I.dvisor tells us that NHNKY and CNMD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NHNKY and CNMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NHNKY
1D Price
Change %
NHNKY100%
+1.27%
CNMD - NHNKY
29%
Poorly correlated
-0.32%
BAX - NHNKY
26%
Poorly correlated
-0.36%
PSNL - NHNKY
25%
Poorly correlated
+3.30%
TRUMY - NHNKY
25%
Poorly correlated
+0.97%
LMAT - NHNKY
24%
Poorly correlated
+0.21%
More